Radioprotection of plasmid and cellular DNA and Swiss mice by silibinin

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 695, Issue 1-2, 2010, Pages 55-60

  Tiwari, Prabha ^a   Kumar, Amit ^a   Ali, Manjoor ^a   Mishra, K P ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Human blood lymphocytes; Radioprotection; Silibinin; Swiss mice

Indexed keywords

CELL DNA; REACTIVE OXYGEN METABOLITE; SILIBININ; ANTIOXIDANT; RADIOPROTECTIVE AGENT; SILYMARIN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; FEMALE; GAMMA RADIATION; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LYMPHOCYTE; MALE; MICRONUCLEUS; MORTALITY; MOUSE; NONHUMAN; NORMAL HUMAN; PLASMID; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION PROTECTION; SWISS WEBSTER MOUSE; WHOLE BODY RADIATION; ANIMAL; DOSE RESPONSE; DRUG EFFECT; GENETICS; METABOLISM; ORAL DRUG ADMINISTRATION; RADIATION DOSE; RADIATION RESPONSE;

ANIMALIA; MUS; SILYBUM MARIANUM;

ADMINISTRATION, ORAL; ADULT; ANIMALS; ANTIOXIDANTS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GAMMA RAYS; HUMANS; LYMPHOCYTES; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; PLASMIDS; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; REACTIVE OXYGEN SPECIES; SILYMARIN; WHOLE-BODY IRRADIATION;

EID: 77950352464     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.11.007     Document Type: Article

References (35)

1. Weiss J.F., Landauer M.R. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 2003, 189:1-20.
2. Yuhas J.M., Spellman J.M., Culo F. The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin. Trials 1980, 3:211-216.
3. Landauer M.R., Davis H.D., Kumar K.S., Weiss J.F. Behavioral toxicity of selected radioprotectors. Adv. Space Res. 1992, 12:273-283.
4. Sandhya T., Lathika K.M., Pandey B.N., Bhilwade H.N., Chaubey R.C., Priyadarsini K.I., Mishra K.P. Protection against radiation oxidative damage in mice by Triphala. Mutat. Res. 2006, 609:17-25.
5. Pandey B.N., Mishra K.P. Modification of thymocytes membrane radio-oxidative damage and apoptosis by eugenol. J. Environ. Pathol. Toxicol. Oncol. 2004, 23:117-122.
6. Kumaran S.P., Kutty B.C., Chatterji A., Subrayan P.P., Mishra K.P. Radioprotection against DNA damage by an extract of Indian green mussel, Perna viridis (L). J. Environ. Pathol. Toxicol. Oncol. 2007, 26:263-272.
7. Tiwari P., Kumar A., Balakrishnan S., Kushwaha H.S., Mishra K.P. Radiation-induced micronucleus formation and DNA damage in human lymphocytes and their prevention by antioxidant thiols. Mutat. Res. 2009, 676:62-68.
8. Bors W., Heller W., Michel C., Saran M. Flavonoids as antioxidant: determination of radical scavenging efficiencies. Methods Enzymol. 1990, 186:343-355.
9. Saija A., Scalese M., Lanza M., Marzullo D., Bonina F., Castelli F. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic. Biol. Med. 1995, 19:481-486.
10. Ross J.A., Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002, 22:19-34.
11. Martinez M.E., Marshall J.R., Giovannucci E. Diet and cancer prevention: the roles of observation and experimentation. Nat. Rev. 2008, 8:694-699.
12. Post-White J., Ladas E.J., Kelly K.M. Advances in the use of milk thistle (Silybum marianum). Integr. Cancer Ther. 2007, 6:104-109.
13. Montvale N.J. Milk thistle (Silybum marianum) in PDR for herbal medicines. Med. Econ. Comp. 2000, 516-520.
14. Wellington K., Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 2001, 15:465-489.
15. Mira L., Silva M., Manso C.F. Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem. Pharmacol. 1989, 48:753-759.
16. Trappoliere M., Caligiuri A., Schmid M., Bertolani C., Failli P., Vizzutti F., Novo E., di Manzano C., Marra F., Loguercio C., Pinzani M. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. J. Hepatol. 2009, 50:1102-1111.
17. Valenzuela A., Monica A., Soledad V., Richardo G. Selectivity of silymarin on the increase of the glutathione content in different tissues of the rats. Planta Med. 1989, 55:420-422.
18. Zhao J., Lahiri-Chatterjee M., Sharma Y., Agarwal R. Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin. Carcinogenesis 2000, 21:811-816.
19. Toklu H.Z., Tunali-Akbay T., Erkanli G., Yuksel M., Ercan F., Sener G. Silymarin, the antioxidant-component of Silybum marianum, protects against burn-induced oxidative injury. Burns 2007, 33:908-916.
20. Nencini C., Giorgi G., Micheli L. Protective effect of silymarin on oxidative stress in rat brain. Phytomedicine 2007, 14:129-135.
21. Toklu H.Z., Tunali-Akbay T., Velioglu-Ogunc A., Ercan F., Gedik N., Keyer-Uysal M., Sener G. Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury. J. Surg. Res. 2008, 145:214-222.
22. Hakova H., Misurova E. The effect of flavobion on nucleic acids in tissues of rats irradiated with gamma rays. Bull. Exp. Biol. Med. 1992, 3:275-277.
23. Dhanalakshmi S., Mallikarjuna G.U., Singh R.P., Agarwal R. Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis. Carcinogenesis 2004, 25:1459-1465.
24. Svobodová A., Zdarilová A., Walterová D., Vostálová J. Flavonolignans from Silybum marianum moderate UVA-induced oxidative damage to HaCaT keratinocytes. J. Dermatol. Sci. 2007, 48:213-224.
25. Ramdan L.A., Roushdy H.M., Abu Senaa G.M., Amin N.E., El-Deshw O.A. Radioprotective effect of silymarin against radiation induced hepatotoxicity. Pharmacol. Res. 2002, 45:447-454.
26. Olive P.L. The role of DNA single- and double-strand breaks in cell killing by ionizing radiation. Radiat. Res. 1998, 150:42-51.
27. Amin A.R., Kucuk O., Khuri F.R., Shin D.M. Perspectives for cancer prevention with natural compounds. J. Clin. Oncol. 2009, 27:2712-2725.
28. Radiobiology for the Radiologist 2006, Lippincott Williams & Wilkins, Philadelphia. E.J. Hall, A.J. Giaccia (Eds.).
29. Agrawal C., Singh R.P., Dhanalakshmi S., Tyagi A.K., Tecklenburg M., Sclafani R.A., Agarwal R. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 2003, 22:8271-8282.
30. Flaig T.W., Gustafson D.L., Su L., Zirrolli J.A., Crighton F., Harrison G.S., Pierson A.S., Agarwal R., Glode L.M. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest. New Drugs 2007, 25:139-146.
31. Jacquet P., de Saint-Georges L., Barrio S., Baugnet-Mahieu L. Morphological effects of caffeine, okadaic acid and genistein in one-cell mouse embryos blocked in G2 by X-irradiation. Int. J. Radiat. Biol. 1995, 67:347-358.
32. Shimoi K., Masuda S., Shen B., Furugori M., Kinae N. Radioprotective effects of antioxidative plant flavonoids in mice. Mutat. Res. 1996, 350:153-161.
33. Jagetia G.C., Reddy T.K. The grapefruit flavanone naringin protects against the radiation-induced genomic instability in the mice bone marrow: a micronucleus study. Mutat. Res. 2002, 519:37-48.
34. Oliveira N.G., Neves M., Rodrigues A.S., Monteiro Gil O., Chaveca T., Rueff J. Assessment of the adaptive response induced by quercetin using the MNCB peripheral blood human lymphocytes assay. Mutagenesis 2000, 15:77-83.
35. Lamson D.W., Brignall M.S. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern. Med. Rev. 1999, 4:304-329.